Quantitative Medical Imaging for Clinical Research and Practice: Nov. 27, 11am-12:30pm

An expert panel introduces quantitative imaging biomarkers for diagnosis and clinical trial outcome measures by reviewing cases from multiple modalities and various organ systems. Panelists demonstrate quantitative measurements from PET/CT and techniques for DCE-MRI analysis.

When: Sunday, Nov. 27, 11:00 to 12:30
Where: S401CD

Speaker information:
Valerie Humblet, medical imaging liaison at Harvard Catalyst-Harvard Medical School, Boston
Katarzyna Macura, MD, PhD, associate professor of radiology, John Hopkins Medicine, Baltimore
Wendy Plesniak, PhD, instructor, radiology, Brigham & Women’s Hospital, Boston
Randy Gollub, MD, PhD, director, biomedical imaging core, Harvard Catalyst at Massachusetts General Hospital, Boston
Ron Kikinis, MD, drector, surgical planning laboratory, Brigham & Women's Hospital, Boston

Around the web

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.